HEADER HYDROLASE 23-OCT-18 6IMW TITLE THE COMPLEX STRUCTURE OF ENDO-BETA-1,2-GLUCANASE MUTANT (E262Q) FROM TITLE 2 TALAROMYCES FUNICULOSUS WITH BETA-1,2-GLUCAN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDO-BETA-1,2-GLUCANASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.2.1.71; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TALAROMYCES FUNICULOSUS; SOURCE 3 ORGANISM_TAXID: 28572; SOURCE 4 ATCC: 11797; SOURCE 5 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: KM71H KEYWDS GLYCOSIDE HYDROLASE, TALAROMYCES FUNICULOSUS, SOPHOROSE, COMPLEX, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR N.TANAKA,M.NAKAJIMA,M.NARUKAWA-NARA,H.MATSUNAGA,S.KAMISUKI,H.ARAMASA, AUTHOR 2 Y.TAKAHASHI,N.SUGIMOTO,K.ABE,A.MIYANAGA,T.YAMASHITA,F.SUGAWARA, AUTHOR 3 T.KAMAKURA,S.KOMBA,H.NAKAI,H.TAGUCHI REVDAT 4 22-NOV-23 6IMW 1 HETSYN REVDAT 3 29-JUL-20 6IMW 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 22-MAY-19 6IMW 1 JRNL REVDAT 1 10-APR-19 6IMW 0 JRNL AUTH N.TANAKA,M.NAKAJIMA,M.NARUKAWA-NARA,H.MATSUNAGA,S.KAMISUKI, JRNL AUTH 2 H.ARAMASA,Y.TAKAHASHI,N.SUGIMOTO,K.ABE,T.TERADA,A.MIYANAGA, JRNL AUTH 3 T.YAMASHITA,F.SUGAWARA,T.KAMAKURA,S.KOMBA,H.NAKAI,H.TAGUCHI JRNL TITL IDENTIFICATION, CHARACTERIZATION, AND STRUCTURAL ANALYSES OF JRNL TITL 2 A FUNGAL ENDO-BETA-1,2-GLUCANASE REVEAL A NEW GLYCOSIDE JRNL TITL 3 HYDROLASE FAMILY. JRNL REF J.BIOL.CHEM. V. 294 7942 2019 JRNL REFN ESSN 1083-351X JRNL PMID 30926603 JRNL DOI 10.1074/JBC.RA118.007087 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0230 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 56981 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3029 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4139 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE SET COUNT : 227 REMARK 3 BIN FREE R VALUE : 0.3600 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7816 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 260 REMARK 3 SOLVENT ATOMS : 253 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.02000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.266 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.193 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.159 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.329 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8332 ; 0.006 ; 0.014 REMARK 3 BOND LENGTHS OTHERS (A): 7100 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11395 ; 1.112 ; 1.696 REMARK 3 BOND ANGLES OTHERS (DEGREES): 16618 ; 0.863 ; 1.671 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 988 ; 6.718 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 413 ;37.574 ;23.753 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1236 ;13.555 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;20.506 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1137 ; 0.055 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 9230 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1638 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3955 ; 0.809 ; 1.945 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 3954 ; 0.809 ; 1.945 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4942 ; 1.339 ; 2.916 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 4943 ; 1.339 ; 2.916 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4377 ; 1.041 ; 2.068 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 4377 ; 1.040 ; 2.068 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 6454 ; 1.691 ; 3.070 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 9760 ; 2.438 ;22.903 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 9711 ; 2.422 ;22.903 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 24 517 B 24 517 17792 0.04 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6IMW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1300009436. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAY-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-5A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS JUNE 1, 2017 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.3 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60060 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 46.640 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.18400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : 0.81200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP 7.0.014 REMARK 200 STARTING MODEL: 6IMU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CITRATE BUFFER (PH 4.0), 0.1M REMARK 280 NACL, 25%(W/V) PEG2000, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 46.08450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.96200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 46.08450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.96200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 13 REMARK 465 GLY A 14 REMARK 465 ILE A 15 REMARK 465 HIS A 16 REMARK 465 HIS A 17 REMARK 465 HIS A 18 REMARK 465 HIS A 19 REMARK 465 HIS A 20 REMARK 465 HIS A 21 REMARK 465 SER A 22 REMARK 465 SER A 23 REMARK 465 ALA B 13 REMARK 465 GLY B 14 REMARK 465 ILE B 15 REMARK 465 HIS B 16 REMARK 465 HIS B 17 REMARK 465 HIS B 18 REMARK 465 HIS B 19 REMARK 465 HIS B 20 REMARK 465 HIS B 21 REMARK 465 SER B 22 REMARK 465 SER B 23 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 28 48.99 -97.22 REMARK 500 ASN A 60 -7.77 70.74 REMARK 500 THR A 84 -75.52 -119.69 REMARK 500 SER A 117 58.43 -159.95 REMARK 500 TYR A 261 -149.91 -91.17 REMARK 500 TRP A 319 -39.60 -39.78 REMARK 500 PRO A 353 23.21 -79.91 REMARK 500 LYS A 448 -52.75 -130.65 REMARK 500 CYS A 516 85.13 -151.10 REMARK 500 ARG B 28 49.24 -97.05 REMARK 500 ASN B 60 -6.96 71.08 REMARK 500 THR B 84 -76.07 -118.90 REMARK 500 SER B 90 -169.09 -161.14 REMARK 500 SER B 117 57.47 -161.79 REMARK 500 PRO B 241 158.51 -49.98 REMARK 500 TYR B 261 -150.90 -90.90 REMARK 500 ASN B 376 59.81 -95.87 REMARK 500 LYS B 448 -52.48 -131.43 REMARK 500 CYS B 516 84.54 -150.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6IMU RELATED DB: PDB REMARK 900 6IMU IS THE APO-STRUCTURE OF THE SAME PROTEIN. REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE AUTHORS SUBMITTED THE SEQUENCE INFORMATION TO DDBJ AND THE REMARK 999 ACCESSION NUMBER (LC430902) WAS ASSIGNED. DBREF 6IMW A 13 517 PDB 6IMW 6IMW 13 517 DBREF 6IMW B 13 517 PDB 6IMW 6IMW 13 517 SEQRES 1 A 505 ALA GLY ILE HIS HIS HIS HIS HIS HIS SER SER GLU PRO SEQRES 2 A 505 SER CYS ARG PHE ALA HIS GLN TYR THR GLN GLU GLN VAL SEQRES 3 A 505 LEU GLN ASN PRO SER LYS PHE ILE ASN ASP VAL LEU PHE SEQRES 4 A 505 TRP GLU GLY LYS PHE HIS GLN ASN ASN ILE SER TYR ASN SEQRES 5 A 505 SER GLY ASN GLY MET SER TYR ASP GLY THR ASN ILE ASP SEQRES 6 A 505 TRP VAL THR GLY GLU GLY THR VAL LYS HIS PRO PHE SER SEQRES 7 A 505 ALA ALA SER LYS GLU SER LEU GLN VAL MET LEU TYR ALA SEQRES 8 A 505 HIS ALA ILE ALA GLY SER ALA ASP ALA ALA ARG PHE LEU SEQRES 9 A 505 SER PRO ASN ASN PRO SER ALA ALA PRO GLY ILE ALA ALA SEQRES 10 A 505 SER ILE MET ASP THR LYS LEU GLN THR TYR LEU ARG PHE SEQRES 11 A 505 ASN GLU THR TYR PRO GLY PHE GLY GLY PHE LEU PRO TRP SEQRES 12 A 505 PHE THR SER SER SER GLN ASP LEU THR PRO THR TRP ASP SEQRES 13 A 505 TRP ASN ASN ARG VAL PRO GLY LEU ASP ASN GLY GLU LEU SEQRES 14 A 505 LEU TRP ALA VAL TYR ALA PHE ILE GLN ALA ALA GLU ASN SEQRES 15 A 505 THR SER ASN LYS SER PHE ILE ASP LEU ALA LYS LYS TRP SEQRES 16 A 505 GLN THR TRP MET ASP TYR THR LYS THR THR ALA ALA HIS SEQRES 17 A 505 ILE PHE TYR GLN GLY GLU GLY LYS VAL CYS ALA VAL THR SEQRES 18 A 505 ASP ILE LYS ASN GLN SER LEU PRO VAL TYR HIS PRO GLU SEQRES 19 A 505 GLN THR TYR ALA CYS GLU GLY THR SER TYR LEU ASN ASP SEQRES 20 A 505 PRO TYR GLN GLY GLU LEU PHE THR TRP TRP LEU GLN PHE SEQRES 21 A 505 PHE GLY GLY LEU SER ASP ALA ASP ILE GLU ALA LEU TRP SEQRES 22 A 505 GLU TYR LYS ARG PRO GLN LEU VAL SER VAL ASP TYR HIS SEQRES 23 A 505 ILE GLY ASN VAL GLY PRO ILE THR VAL GLN LYS GLY TYR SEQRES 24 A 505 TRP PHE SER SER HIS GLU THR TRP LYS VAL LEU GLU MET SEQRES 25 A 505 PRO TYR TYR ASP ILE ASP ILE ILE ARG ARG VAL PHE GLN SEQRES 26 A 505 ASN ALA GLU ARG ALA ARG THR CYS ASN SER VAL VAL THR SEQRES 27 A 505 GLN VAL PRO GLY MET PHE ALA SER ILE ASN ASN VAL THR SEQRES 28 A 505 ASP PRO ALA THR GLY ASP VAL VAL GLY TYR ILE SER ASN SEQRES 29 A 505 ALA GLY ILE PRO SER ILE ALA ASN GLN THR ILE GLN GLU SEQRES 30 A 505 LEU ASP VAL ILE THR PRO TYR SER VAL PHE PRO THR VAL SEQRES 31 A 505 LEU PHE ASP LYS GLY VAL GLY MET ALA TRP TRP ARG ASN SEQRES 32 A 505 MET ALA ILE GLY LYS LYS MET GLN ASN ILE TYR GLY SER SEQRES 33 A 505 THR GLU SER THR ARG ARG ASP GLY THR GLY VAL SER ALA SEQRES 34 A 505 LEU LEU THR TRP ASP SER LYS VAL SER THR VAL ASN ALA SEQRES 35 A 505 ILE LEU GLY GLY VAL SER GLY LEU VAL SER GLN LYS MET SEQRES 36 A 505 LYS ALA GLU ASN ILE TYR ASN THR PHE VAL GLU ARG ILE SEQRES 37 A 505 GLU ALA GLU TYR SER ARG VAL PHE LYS ASN LEU LYS GLY SEQRES 38 A 505 GLU HIS VAL PRO PHE CYS LEU PRO GLN GLU THR VAL PRO SEQRES 39 A 505 ASP THR GLY LEU VAL ASP PHE THR THR CYS ASN SEQRES 1 B 505 ALA GLY ILE HIS HIS HIS HIS HIS HIS SER SER GLU PRO SEQRES 2 B 505 SER CYS ARG PHE ALA HIS GLN TYR THR GLN GLU GLN VAL SEQRES 3 B 505 LEU GLN ASN PRO SER LYS PHE ILE ASN ASP VAL LEU PHE SEQRES 4 B 505 TRP GLU GLY LYS PHE HIS GLN ASN ASN ILE SER TYR ASN SEQRES 5 B 505 SER GLY ASN GLY MET SER TYR ASP GLY THR ASN ILE ASP SEQRES 6 B 505 TRP VAL THR GLY GLU GLY THR VAL LYS HIS PRO PHE SER SEQRES 7 B 505 ALA ALA SER LYS GLU SER LEU GLN VAL MET LEU TYR ALA SEQRES 8 B 505 HIS ALA ILE ALA GLY SER ALA ASP ALA ALA ARG PHE LEU SEQRES 9 B 505 SER PRO ASN ASN PRO SER ALA ALA PRO GLY ILE ALA ALA SEQRES 10 B 505 SER ILE MET ASP THR LYS LEU GLN THR TYR LEU ARG PHE SEQRES 11 B 505 ASN GLU THR TYR PRO GLY PHE GLY GLY PHE LEU PRO TRP SEQRES 12 B 505 PHE THR SER SER SER GLN ASP LEU THR PRO THR TRP ASP SEQRES 13 B 505 TRP ASN ASN ARG VAL PRO GLY LEU ASP ASN GLY GLU LEU SEQRES 14 B 505 LEU TRP ALA VAL TYR ALA PHE ILE GLN ALA ALA GLU ASN SEQRES 15 B 505 THR SER ASN LYS SER PHE ILE ASP LEU ALA LYS LYS TRP SEQRES 16 B 505 GLN THR TRP MET ASP TYR THR LYS THR THR ALA ALA HIS SEQRES 17 B 505 ILE PHE TYR GLN GLY GLU GLY LYS VAL CYS ALA VAL THR SEQRES 18 B 505 ASP ILE LYS ASN GLN SER LEU PRO VAL TYR HIS PRO GLU SEQRES 19 B 505 GLN THR TYR ALA CYS GLU GLY THR SER TYR LEU ASN ASP SEQRES 20 B 505 PRO TYR GLN GLY GLU LEU PHE THR TRP TRP LEU GLN PHE SEQRES 21 B 505 PHE GLY GLY LEU SER ASP ALA ASP ILE GLU ALA LEU TRP SEQRES 22 B 505 GLU TYR LYS ARG PRO GLN LEU VAL SER VAL ASP TYR HIS SEQRES 23 B 505 ILE GLY ASN VAL GLY PRO ILE THR VAL GLN LYS GLY TYR SEQRES 24 B 505 TRP PHE SER SER HIS GLU THR TRP LYS VAL LEU GLU MET SEQRES 25 B 505 PRO TYR TYR ASP ILE ASP ILE ILE ARG ARG VAL PHE GLN SEQRES 26 B 505 ASN ALA GLU ARG ALA ARG THR CYS ASN SER VAL VAL THR SEQRES 27 B 505 GLN VAL PRO GLY MET PHE ALA SER ILE ASN ASN VAL THR SEQRES 28 B 505 ASP PRO ALA THR GLY ASP VAL VAL GLY TYR ILE SER ASN SEQRES 29 B 505 ALA GLY ILE PRO SER ILE ALA ASN GLN THR ILE GLN GLU SEQRES 30 B 505 LEU ASP VAL ILE THR PRO TYR SER VAL PHE PRO THR VAL SEQRES 31 B 505 LEU PHE ASP LYS GLY VAL GLY MET ALA TRP TRP ARG ASN SEQRES 32 B 505 MET ALA ILE GLY LYS LYS MET GLN ASN ILE TYR GLY SER SEQRES 33 B 505 THR GLU SER THR ARG ARG ASP GLY THR GLY VAL SER ALA SEQRES 34 B 505 LEU LEU THR TRP ASP SER LYS VAL SER THR VAL ASN ALA SEQRES 35 B 505 ILE LEU GLY GLY VAL SER GLY LEU VAL SER GLN LYS MET SEQRES 36 B 505 LYS ALA GLU ASN ILE TYR ASN THR PHE VAL GLU ARG ILE SEQRES 37 B 505 GLU ALA GLU TYR SER ARG VAL PHE LYS ASN LEU LYS GLY SEQRES 38 B 505 GLU HIS VAL PRO PHE CYS LEU PRO GLN GLU THR VAL PRO SEQRES 39 B 505 ASP THR GLY LEU VAL ASP PHE THR THR CYS ASN HET BGC C 1 12 HET BGC C 2 11 HET BGC C 3 11 HET BGC C 4 11 HET BGC C 5 11 HET BGC D 1 12 HET BGC D 2 11 HET BGC D 3 11 HET BGC D 4 11 HET BGC D 5 11 HET BGC D 6 11 HET BGC D 7 11 HET NAG A 601 14 HET NAG A 602 14 HET NAG A 603 14 HET NAG A 604 14 HET NAG B 601 14 HET NAG B 602 14 HET NAG B 603 14 HET NAG B 604 14 HET PEG B 605 7 HET PEG B 606 7 HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM PEG DI(HYDROXYETHYL)ETHER HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 BGC 12(C6 H12 O6) FORMUL 5 NAG 8(C8 H15 N O6) FORMUL 13 PEG 2(C4 H10 O3) FORMUL 15 HOH *253(H2 O) HELIX 1 AA1 ARG A 28 TYR A 33 5 6 HELIX 2 AA2 THR A 34 ASN A 41 1 8 HELIX 3 AA3 ASN A 41 LYS A 55 1 15 HELIX 4 AA4 ALA A 91 GLY A 108 1 18 HELIX 5 AA5 SER A 109 SER A 117 1 9 HELIX 6 AA6 ASN A 120 SER A 122 5 3 HELIX 7 AA7 ALA A 123 TYR A 146 1 24 HELIX 8 AA8 PRO A 147 GLY A 150 5 4 HELIX 9 AA9 TRP A 167 ASN A 170 5 4 HELIX 10 AB1 GLY A 175 ASN A 194 1 20 HELIX 11 AB2 ASN A 197 PHE A 222 1 26 HELIX 12 AB3 GLY A 263 GLY A 274 1 12 HELIX 13 AB4 SER A 277 ARG A 289 1 13 HELIX 14 AB5 PRO A 290 LEU A 292 5 3 HELIX 15 AB6 SER A 314 GLU A 323 5 10 HELIX 16 AB7 PRO A 325 ASP A 328 5 4 HELIX 17 AB8 ILE A 329 THR A 350 1 22 HELIX 18 AB9 ILE A 379 ALA A 383 5 5 HELIX 19 AC1 THR A 394 SER A 397 5 4 HELIX 20 AC2 VAL A 398 ASP A 405 1 8 HELIX 21 AC3 ASP A 405 ILE A 418 1 14 HELIX 22 AC4 TRP A 445 LEU A 456 1 12 HELIX 23 AC5 VAL A 459 GLU A 470 1 12 HELIX 24 AC6 ILE A 472 PHE A 488 1 17 HELIX 25 AC7 ARG B 28 TYR B 33 5 6 HELIX 26 AC8 THR B 34 ASN B 41 1 8 HELIX 27 AC9 ASN B 41 GLY B 54 1 14 HELIX 28 AD1 LYS B 55 HIS B 57 5 3 HELIX 29 AD2 ALA B 91 GLY B 108 1 18 HELIX 30 AD3 SER B 109 SER B 117 1 9 HELIX 31 AD4 ASN B 120 SER B 122 5 3 HELIX 32 AD5 ALA B 123 TYR B 146 1 24 HELIX 33 AD6 PRO B 147 GLY B 150 5 4 HELIX 34 AD7 TRP B 167 ASN B 170 5 4 HELIX 35 AD8 GLY B 175 ASN B 194 1 20 HELIX 36 AD9 ASN B 197 PHE B 222 1 26 HELIX 37 AE1 GLY B 263 GLY B 274 1 12 HELIX 38 AE2 SER B 277 ARG B 289 1 13 HELIX 39 AE3 PRO B 290 LEU B 292 5 3 HELIX 40 AE4 SER B 314 GLU B 323 5 10 HELIX 41 AE5 PRO B 325 ASP B 328 5 4 HELIX 42 AE6 ILE B 329 THR B 350 1 22 HELIX 43 AE7 ILE B 379 ALA B 383 5 5 HELIX 44 AE8 THR B 394 SER B 397 5 4 HELIX 45 AE9 VAL B 398 ASP B 405 1 8 HELIX 46 AF1 ASP B 405 ILE B 418 1 14 HELIX 47 AF2 TRP B 445 LEU B 456 1 12 HELIX 48 AF3 VAL B 459 GLU B 470 1 12 HELIX 49 AF4 ILE B 472 PHE B 488 1 17 SHEET 1 AA1 2 TYR A 63 ASN A 64 0 SHEET 2 AA1 2 MET A 69 SER A 70 -1 O MET A 69 N ASN A 64 SHEET 1 AA2 3 GLY A 83 HIS A 87 0 SHEET 2 AA2 3 GLY A 73 ILE A 76 -1 N ASN A 75 O VAL A 85 SHEET 3 AA2 3 LEU A 442 THR A 444 -1 O LEU A 443 N THR A 74 SHEET 1 AA3 3 PHE A 89 SER A 90 0 SHEET 2 AA3 3 PHE A 156 THR A 157 -1 O PHE A 156 N SER A 90 SHEET 3 AA3 3 THR A 164 PRO A 165 -1 O THR A 164 N THR A 157 SHEET 1 AA4 3 ARG A 172 PRO A 174 0 SHEET 2 AA4 3 VAL A 232 ILE A 235 -1 O THR A 233 N VAL A 173 SHEET 3 AA4 3 TYR A 249 CYS A 251 -1 O ALA A 250 N ASP A 234 SHEET 1 AA5 2 TYR A 223 GLY A 225 0 SHEET 2 AA5 2 LYS A 228 VAL A 229 -1 O LYS A 228 N GLN A 224 SHEET 1 AA6 2 SER A 294 ILE A 299 0 SHEET 2 AA6 2 VAL A 302 GLN A 308 -1 O VAL A 307 N VAL A 295 SHEET 1 AA7 2 ILE A 359 ASN A 360 0 SHEET 2 AA7 2 TYR A 373 ILE A 374 -1 O ILE A 374 N ILE A 359 SHEET 1 AA8 3 VAL A 392 ILE A 393 0 SHEET 2 AA8 3 SER A 431 ARG A 433 -1 O THR A 432 N ILE A 393 SHEET 3 AA8 3 VAL A 439 SER A 440 -1 O SER A 440 N SER A 431 SHEET 1 AA9 2 GLN A 423 ASN A 424 0 SHEET 2 AA9 2 GLY A 427 SER A 428 -1 O GLY A 427 N ASN A 424 SHEET 1 AB1 2 TYR B 63 ASN B 64 0 SHEET 2 AB1 2 MET B 69 SER B 70 -1 O MET B 69 N ASN B 64 SHEET 1 AB2 3 GLY B 83 HIS B 87 0 SHEET 2 AB2 3 GLY B 73 ILE B 76 -1 N ASN B 75 O VAL B 85 SHEET 3 AB2 3 LEU B 442 THR B 444 -1 O LEU B 443 N THR B 74 SHEET 1 AB3 3 PHE B 89 SER B 90 0 SHEET 2 AB3 3 PHE B 156 THR B 157 -1 O PHE B 156 N SER B 90 SHEET 3 AB3 3 THR B 164 PRO B 165 -1 O THR B 164 N THR B 157 SHEET 1 AB4 3 ARG B 172 PRO B 174 0 SHEET 2 AB4 3 VAL B 232 ILE B 235 -1 O THR B 233 N VAL B 173 SHEET 3 AB4 3 TYR B 249 CYS B 251 -1 O ALA B 250 N ASP B 234 SHEET 1 AB5 2 TYR B 223 GLY B 225 0 SHEET 2 AB5 2 LYS B 228 VAL B 229 -1 O LYS B 228 N GLN B 224 SHEET 1 AB6 2 SER B 294 ILE B 299 0 SHEET 2 AB6 2 VAL B 302 GLN B 308 -1 O VAL B 307 N VAL B 295 SHEET 1 AB7 2 ILE B 359 ASN B 360 0 SHEET 2 AB7 2 TYR B 373 ILE B 374 -1 O ILE B 374 N ILE B 359 SHEET 1 AB8 3 VAL B 392 ILE B 393 0 SHEET 2 AB8 3 SER B 431 ARG B 433 -1 O THR B 432 N ILE B 393 SHEET 3 AB8 3 VAL B 439 SER B 440 -1 O SER B 440 N SER B 431 SHEET 1 AB9 2 GLN B 423 ASN B 424 0 SHEET 2 AB9 2 GLY B 427 SER B 428 -1 O GLY B 427 N ASN B 424 SSBOND 1 CYS A 27 CYS A 516 1555 1555 2.04 SSBOND 2 CYS A 230 CYS A 251 1555 1555 2.03 SSBOND 3 CYS A 345 CYS A 499 1555 1555 2.08 SSBOND 4 CYS B 27 CYS B 516 1555 1555 2.05 SSBOND 5 CYS B 230 CYS B 251 1555 1555 2.03 SSBOND 6 CYS B 345 CYS B 499 1555 1555 2.07 LINK ND2 ASN A 143 C1 NAG A 601 1555 1555 1.46 LINK ND2 ASN A 237 C1 NAG A 602 1555 1555 1.43 LINK ND2 ASN A 361 C1 NAG A 603 1555 1555 1.45 LINK ND2 ASN A 384 C1 NAG A 604 1555 1555 1.44 LINK ND2 ASN B 143 C1 NAG B 601 1555 1555 1.44 LINK ND2 ASN B 237 C1 NAG B 602 1555 1555 1.45 LINK ND2 ASN B 361 C1 NAG B 603 1555 1555 1.44 LINK ND2 ASN B 384 C1 NAG B 604 1555 1555 1.43 LINK O2 BGC C 1 C1 BGC C 2 1555 1555 1.45 LINK O2 BGC C 2 C1 BGC C 3 1555 1555 1.44 LINK O2 BGC C 3 C1 BGC C 4 1555 1555 1.43 LINK O2 BGC C 4 C1 BGC C 5 1555 1555 1.43 LINK O2 BGC D 1 C1 BGC D 2 1555 1555 1.42 LINK O2 BGC D 2 C1 BGC D 3 1555 1555 1.45 LINK O2 BGC D 3 C1 BGC D 4 1555 1555 1.46 LINK O2 BGC D 4 C1 BGC D 5 1555 1555 1.41 LINK O2 BGC D 5 C1 BGC D 6 1555 1555 1.41 LINK O2 BGC D 6 C1 BGC D 7 1555 1555 1.45 CISPEP 1 GLY A 303 PRO A 304 0 7.02 CISPEP 2 GLY B 303 PRO B 304 0 8.08 CRYST1 92.169 117.924 93.284 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010850 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008480 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010720 0.00000